Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

Clin Endocrinol (Oxf). 2006 Aug;65(2):265-73. doi: 10.1111/j.1365-2265.2006.02562.x.

Abstract

In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during the 9th International Pituitary Congress in San Diego, California. Members of this committee consisted of invited international experts in the field, and included endocrinologists and neurosurgeons with recognized expertise in the management of prolactinomas. Discussions were held that included all interested participants to the Congress and resulted in formulation of these guidelines, which represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.

Publication types

  • Practice Guideline

MeSH terms

  • Adenoma / diagnosis
  • Adenoma / therapy
  • Adult
  • Algorithms*
  • Child
  • Dopamine Agonists / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperprolactinemia / diagnosis
  • Hyperprolactinemia / etiology
  • Hyperprolactinemia / therapy
  • Male
  • Pituitary Neoplasms* / diagnosis
  • Pituitary Neoplasms* / therapy
  • Pregnancy
  • Pregnancy Complications, Neoplastic* / diagnosis
  • Pregnancy Complications, Neoplastic* / therapy
  • Prolactinoma* / diagnosis
  • Prolactinoma* / therapy

Substances

  • Dopamine Agonists